Interleukin-18 as a Potential Biomarker for Radiotherapy-Related Pain in Breast Cancer: Implications for Personalized Pain Management.

McMahon AN, de Rivero Vaccari JP, Reis IM, Takita C, Wright JL, Guo Y, Hu JJ

Open source

DOI
10.3390/cancers18071100
Published
2026 Mar 28
Container
Cancers
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers18071100,
  title = {Interleukin-18 as a Potential Biomarker for Radiotherapy-Related Pain in Breast Cancer: Implications for Personalized Pain Management.},
  author = {McMahon AN and de Rivero Vaccari JP and Reis IM and Takita C and Wright JL and Guo Y and Hu JJ},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18071100},
  url = {https://doi.org/10.3390/cancers18071100}
}

RIS

TY  - JOUR
TI  - Interleukin-18 as a Potential Biomarker for Radiotherapy-Related Pain in Breast Cancer: Implications for Personalized Pain Management.
AU  - McMahon AN
AU  - de Rivero Vaccari JP
AU  - Reis IM
AU  - Takita C
AU  - Wright JL
AU  - Guo Y
AU  - Hu JJ
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18071100
UR  - https://doi.org/10.3390/cancers18071100
ER  - 

APA

AN, M., JP, D. R. V., IM, R., C, T., JL, W., Y, G., & JJ, H. (2026). Interleukin-18 as a Potential Biomarker for Radiotherapy-Related Pain in Breast Cancer: Implications for Personalized Pain Management.. Cancers. https://doi.org/10.3390/cancers18071100

Source records